EUVIMEDEUVIMED entdecken
Crossref

Utilising clinical parameters to improve the selection of nerve biopsy candidates

Paul Kopanidis iD, Georgios Baskozos, Elizabeth Byrne, Monika Hofer, Andreas C Themistocleous, Simon Rinaldi, David L Bennett

Internal Medicine Journal · 2023

DOI: 10.1111/imj.16099 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Internal Medicine Journal, 2023. Verfasst von Paul Kopanidis und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, Northern Health, Melbourne, Victoria, Australia. Hauptthemen laut MEDLINE: Peripheral Nervous System Diseases, Vasculitis. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 15 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Peripheral nerve biopsy is a valuable final diagnostic tool; however, histopathological results can be non‐diagnostic.

Aims

We aim to identify quality improvement measures by evaluating the pre‐biopsy assessment and diagnostic yield of specific histopathological diagnosis.

Methods

This was a retrospective study based on 10 years of experience with peripheral nerve biopsies at a single centre. Clinical data were obtained regarding pre‐biopsy history, examination, serum and cerebrospinal fluid (CSF) investigations, neurophysiology and peripheral nerve imaging. Based upon a histopathological outcome, patients were grouped into vasculitis, granulomatous and infiltrative (diagnostic) group, or a comparison group of non‐specific axonal neuropathy and normal (non‐specific/normal) group.

Results

From a cohort of 64 patients, 21 (32.8%) were included in the diagnostic group and 30 (46.9%) in the non‐specific/normal group. Clinical parameters associated with the diagnostic group were shorter history (mean 10.2 months vs 38.1), stepwise progression (81% vs 20%), neuropathic pain (85.7% vs 56.7%), vasculitic rash (23.8% vs 0%), mononeuritis multiplex (57.1% vs 10%), asymmetry (90.5% vs 60%), raised white cell count (47.6% vs 16.7%), myeloperoxidase antibody (19.1% vs 0%) and abnormal peripheral nerve imaging (33.3% vs 10%).

Conclusion

Selection of patients undergoing nerve biopsy requires careful consideration of clinical parameters, including peripheral nerve imaging. Several quality improvement measures are proposed to improve yield of clinically actionable information from nerve biopsy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Peripheral Nervous System DiseasesVasculitisHumansRetrospective StudiesAntibodies, Antineutrophil CytoplasmicBiopsy

Stichwörter der Autor:innen

diagnostic imagingneuropathologyperipheral nervous system diseasesvasculitis

Substanzen

Antibodies, Antineutrophil Cytoplasmic

Autor:innen und Institutionen

  • Department of Neurology, Northern Health, Melbourne, Victoria, Australia.
  • Department of Neurology, Oxford University Hospitals NHS Foundation Trust, Oxford, UK.
  • Nuffield Department of Clinical Neurosciences, University of Oxford, Oxford, UK.
  • Neuropathology Department, Oxford University Hospitals NHS Foundation Trust, Oxford, UK.

ORCID-Profile: Paul Kopanidis

Zitieren

APA

Kopanidis, P., Baskozos, G., Byrne, E., Hofer, M., Themistocleous, A. C., Rinaldi, S., & Bennett, D. L. (2023). Utilising clinical parameters to improve the selection of nerve biopsy candidates. Internal Medicine Journal. https://doi.org/10.1111/imj.16099

Vancouver

Kopanidis P, Baskozos G, Byrne E, Hofer M, Themistocleous AC, Rinaldi S, et al. Utilising clinical parameters to improve the selection of nerve biopsy candidates. Internal Medicine Journal. 2023. doi:10.1111/imj.16099

BibTeX
@article{Kopanidis2023,
  author = {Kopanidis, Paul and Baskozos, Georgios and Byrne, Elizabeth and Hofer, Monika and Themistocleous, Andreas C and Rinaldi, Simon and Bennett, David L},
  title = {Utilising clinical parameters to improve the selection of nerve biopsy candidates},
  journal = {Internal Medicine Journal},
  year = {2023},
  doi = {10.1111/imj.16099}
}
Kostenlos starten →